Hungary vs Sri Lanka: Cause of death, by non-communicable diseases, female
Hungary
80.5%
in 2021
Sri Lanka
80.6%
in 2021
Hungary rank
37th
Sri Lanka rank
35th
Cause of death, by non-communicable diseases, female over time
- Hungary
- Sri Lanka
How they compare
Sri Lanka currently reports 80.6% against 80.5% in Hungary, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Hungary ahead.
Hungary ranks 37th and Sri Lanka ranks 35th of 185 countries.
Hungary has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hungary | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.1% | 80.5% | 12.6% | Hungary |
| 2010s | 94.9% | 87.4% | 7.5% | Hungary |
| 2020s | 85.1% | 84.9% | 0.2% | Hungary |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Hungary or Sri Lanka?
- Sri Lanka, at 80.6% against 80.5% in Hungary as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Hungary and Sri Lanka?
- 0.1%, with Sri Lanka ahead.
- How many years of comparable data are there for Hungary and Sri Lanka?
- 6 years are reported by both, from 2000 to 2021.
- How do Hungary and Sri Lanka rank globally for cause of death, by non-communicable diseases, female?
- Hungary ranks 37th and Sri Lanka ranks 35th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.